Research Article
Predictive Ability of Serum IL-27 Level for Assessing Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Table 5
Correlation of serum IL-27 level and serum IL-18 level with the total score of each clinical item of BVAS.
| | Serum IL-27 level | Serum 18 level | | Correlation coefficient () | value | Correlation coefficient () | value |
| | General manifestation | 0.084 | 0.468 | 0.011 | 0.924 | | Cutaneous manifestation | -0.062 | 0.590 | 0.043 | 0.707 | | Mucous and ocular manifestation | 0.192 | 0.094 | -0.014 | 0.901 | | Otorhinolaryngologic manifestation | 0.088 | 0.445 | -0.122 | 0.292 | | Pulmonary manifestation | 0.104 | 0.369 | 0.059 | 0.611 | | Cardiovascular manifestation | -0.024 | 0.836 | 0.034 | 0.771 | | Gastrointestinal manifestation | -0.115 | 0.320 | -0.086 | 0.458 | | Renal manifestation | 0.514 | <0.001 | 0.256 | 0.025 | | Nervous systemic manifestation | -0.002 | 0.987 | -0.007 | 0.949 |
|
|
IL: interleukin; BVAS: Birmingham vasculitis activity score.
|
